Screener/Healthcare/Biotechnology

RARE

Ultragenyx Pharmaceutical Inc.NASDAQ
$18.58-1.69 (-8.34%)
Mid CapUnder $20HealthcareFastest GrowingHigh ROELow Beta
$18.29
$42.37
$18.29
$19.40
EPS (TTM)$-5.83
P/E Ratio—
Dividend Yield—
Market Cap$2.15B
Volume2.77M
Prev Close$20.27
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$207.3M-$128.6M$-1.28—-62.0%
Q3 '25$159.9M-$180.4M$-1.81—-112.8%
Q2 '25$166.5M-$115.0M$-1.17—-69.0%
Q1 '25$139.3M-$151.1M$-1.57—-108.5%
Q3 '24$139.5M-$133.5M$-1.40—-95.7%
Q2 '24$147.0M-$131.6M$-1.52—-89.5%
Q1 '24$108.8M-$170.7M$-2.03—-156.8%
Q4 '23$127.4M-$123.2M$-1.44—-96.7%
Get Your Daily Market Recap